Interactive tools

The Weekly Roundup: December 8-12

The Rx Recap: December 7-12

Addressing Delays in Prior Authorization Processes That Negatively Impact Patients

Emerging Topical Alternatives to Hydroquinone in Melasma Management

JAK Inhibitors Show Comparable Safety to TNF Antagonists

Phase 2 Nemolizumab Trial Opens for CPUO

"PDE4 Inhibitor-Responsive Dermatoses": A Modern Framework for Managing Inflammatory Skin Conditions

Mohs Micrographic Surgery in High-Profile Patients: A Call for Expanding Access to Skin Cancer Care

The SkinCARE Questionnaire: Assessing the Psychological Dimensions of Skin Health Beyond Disease

Phase 3b Study Confirms Ligelizumab’s Consistent CSU Control